JA Ligibel

404 total citations
18 papers, 288 citations indexed

About

JA Ligibel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, JA Ligibel has authored 18 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in JA Ligibel's work include Cancer Risks and Factors (6 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer survivorship and care (5 papers). JA Ligibel is often cited by papers focused on Cancer Risks and Factors (6 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer survivorship and care (5 papers). JA Ligibel collaborates with scholars based in United States, Canada and South Korea. JA Ligibel's co-authors include EP Winer, Rhayun Song, Kamila Osypiuk, Peter M. Wayne, Myeong Soo Lee, Linda E. Carlson, Kathleen I. Pritchard, Roanne Segal, Mark N. Levine and Pamela J. Goodwin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

JA Ligibel

18 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JA Ligibel United States 5 174 67 64 45 39 18 288
Maira P. Campos United States 7 163 0.9× 63 0.9× 19 0.3× 19 0.4× 52 1.3× 10 362
S. Patil India 7 196 1.1× 110 1.6× 71 1.1× 18 0.4× 49 1.3× 16 300
Haresh Jhangiani United States 6 67 0.4× 31 0.5× 10 0.2× 20 0.4× 62 1.6× 14 261
Tammy Fischer United States 5 210 1.2× 161 2.4× 34 0.5× 11 0.2× 16 0.4× 7 541
Elan Hahn Canada 11 122 0.7× 61 0.9× 8 0.1× 24 0.5× 30 0.8× 44 274
Calvin L. Cole United States 9 137 0.8× 54 0.8× 16 0.3× 115 2.6× 51 1.3× 25 298
Sadeeka Al‐Majid United States 8 175 1.0× 58 0.9× 23 0.4× 196 4.4× 175 4.5× 12 436
Katsunori Tsuji Japan 11 84 0.5× 34 0.5× 85 1.3× 99 2.2× 31 0.8× 32 349
Valentina Natalucci Italy 9 79 0.5× 23 0.3× 17 0.3× 72 1.6× 35 0.9× 21 221
Kimberly Levenhagen United States 6 264 1.5× 12 0.2× 13 0.2× 40 0.9× 5 0.1× 13 348

Countries citing papers authored by JA Ligibel

Since Specialization
Citations

This map shows the geographic impact of JA Ligibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JA Ligibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JA Ligibel more than expected).

Fields of papers citing papers by JA Ligibel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JA Ligibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JA Ligibel. The network helps show where JA Ligibel may publish in the future.

Co-authorship network of co-authors of JA Ligibel

This figure shows the co-authorship network connecting the top 25 collaborators of JA Ligibel. A scholar is included among the top collaborators of JA Ligibel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JA Ligibel. JA Ligibel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ligibel, JA, Anna Weiss, Tracy E. Crane, et al.. (2024). 1817MO Effect of a weight loss intervention (WLI) on exercise behaviors in women with breast cancer: Results from the breast cancer weight loss (BWEL) trial. Annals of Oncology. 35. S1078–S1078. 1 indexed citations
2.
Ligibel, JA, HS Rugo, HJ Burstein, et al.. (2018). Abstract P1-07-04: Physical activity, weight and outcomes in patients receiving first-line chemotherapy for metastatic breast cancer: Results from CALGB 40502 (Alliance). Cancer Research. 78(4_Supplement). P1–7. 1 indexed citations
3.
Wayne, Peter M., Myeong Soo Lee, Kamila Osypiuk, et al.. (2017). Tai Chi and Qigong for cancer-related symptoms and quality of life: a systematic review and meta-analysis. Journal of Cancer Survivorship. 12(2). 256–267. 162 indexed citations
4.
Ligibel, JA, Melinda L. Irwin, Deborah Dillon, et al.. (2017). Abstract S5-05: Impact of pre-operative exercise on breast cancer gene expression. Cancer Research. 77(4_Supplement). S5–5. 3 indexed citations
5.
Ligibel, JA, Anita Giobbie‐Hurder, Laura Shockro, et al.. (2017). Abstract P5-11-02: Impact of pre-operative exercise and mind-body interventions on patient-reported outcomes in women with newly diagnosed breast cancer. Cancer Research. 77(4_Supplement). P5–11. 2 indexed citations
6.
Lu, Weidong, Anita Giobbie‐Hurder, Rachel A. Freedman, et al.. (2017). Abstract PD4-01: Acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer, preliminary results of a pilot randomized controlled trial. Cancer Research. 77(4_Supplement). PD4–1. 1 indexed citations
7.
Cartmel, Brenda, Elizabeth Ercolano, Martha Fiellin, et al.. (2013). Abstract S3-03: Randomized trial of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with breast cancer: The hormones and physical exercise (HOPE) study. Cancer Research. 73(24_Supplement). S3–3. 14 indexed citations
8.
Ligibel, JA, C. Cirrincione, WJ Gradishar, et al.. (2012). 413 Relationship Between Body Mass Index (BMI) and Outcomes in Node-positive Breast Cancer Patients Receiving Chemotherapy–Results From CALGB/Intergroup 9741. European Journal of Cancer. 48. S166–S167. 1 indexed citations
9.
10.
Ligibel, JA, HJ Burstein, KD Miller, et al.. (2011). OT3-02-04: TBCRC 012: ABCDE, a Phase II Randomized Study of Adjuvant Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise after Preoperative Chemotherapy for Breast Cancer.. Cancer Research. 71(24_Supplement). OT3–2. 3 indexed citations
11.
Parulekar, Wendy R., Catherine Elliott, Lois E. Shepherd, et al.. (2011). A phase III randomized trial of metformin versus placebo on recurrence and survival in early-stage breast cancer (BC) (NCIC Clinical Trials Group MA.32).. Journal of Clinical Oncology. 29(15_suppl). TPS103–TPS103. 8 indexed citations
12.
Cigler, Tessa, Jackie Szymonifka, A. H. Partridge, et al.. (2011). A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy.. Journal of Clinical Oncology. 29(15_suppl). 559–559. 1 indexed citations
13.
Segal, Roanne, Gregory R. Pond, Michael Vallis, et al.. (2011). Randomized trial of a lifestyle intervention for women with early-stage breast cancer (BC) receiving adjuvant hormone therapy: Initial results.. Journal of Clinical Oncology. 29(15_suppl). 512–512. 13 indexed citations
14.
Ligibel, JA, et al.. (2011). P2-17-06: Patterns of Bone Density Evaluation in a Community Population Treated with Aromatase Inhibitors.. Cancer Research. 71(24_Supplement). P2–17. 1 indexed citations
15.
Ligibel, JA, et al.. (2010). Abstract S2-6: Aromatase Inhibitors and Risk of Myocardial Infarction, Stroke and Fracture. Cancer Research. 70(24_Supplement). S2–6. 2 indexed citations
16.
Ligibel, JA, Jeffrey A. Meyerhardt, Julie Najita, et al.. (2010). Abstract PD08-09: Impact of a Telephone-Based Exercise Intervention on Physical Activity Behaviors and Fitness in a Cooperative Group Setting. Cancer Research. 70(24_Supplement). PD08–9. 1 indexed citations
17.
Mayer, Erica L., JA Ligibel, HJ Burstein, et al.. (2010). TBCRC 012: ABCDE, a phase II randomized study of adjuvant bevacizumab, metronomic chemotherapy (CM), diet and exercise after preoperative chemotherapy for breast cancer.. Journal of Clinical Oncology. 28(15_suppl). TPS103–TPS103. 4 indexed citations
18.
Ligibel, JA & EP Winer. (2002). Trastuzumab/chemotherapy combinations in metastatic breast cancer. Seminars in Oncology. 29(3). 38–43. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maira P. Campos Breakdown of academic impact, for papers by S. Patil Breakdown of academic impact, for papers by Haresh Jhangiani Breakdown of academic impact, for papers by Tammy Fischer Breakdown of academic impact, for papers by Elan Hahn Breakdown of academic impact, for papers by Calvin L. Cole Breakdown of academic impact, for papers by Sadeeka Al‐Majid Breakdown of academic impact, for papers by Katsunori Tsuji Breakdown of academic impact, for papers by Valentina Natalucci Breakdown of academic impact, for papers by Kimberly Levenhagen
Rankless by CCL
2026